Skip to main content
Announcements

Sidley Represents Capricor Therapeutics in Common Stock Offering

October 24, 2024

Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 5,073,800 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover overallotments, bringing the total gross proceeds to Capricor from the offering to approximately US$86.3 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering.

The deal team was led by Rob Carlson and included Nick DeAngelis and Nithya Swaminathan.

連絡先

Carlson, Rob R.
パートナー
DeAngelis, Nick
カウンセル
Swaminathan, Nithya
Managing Associate

得意分野

Suggested News & Insights

Sidley Advises on Galaxy Digital’s US$500 Million At-the-Market Equity ProgramMay 14, 2026
Announcements
Sidley Represents GFH as Anchor Investor in the US$5 Billion Dual IPO of Pershing Square Inc. and Pershing Square USAMay 13, 2026
Announcements
Sidley Represents Underwriters in Connection With Pharvaris’ US$115 Million Underwritten Offering of Ordinary SharesMay 8, 2026
Announcements
Sidley Represents Siris Capital in Its US$4.2 Billion Sale of EquinitiMay 5, 2026
Announcements
Sidley Advises on Brookfield India REIT and Poonawalla Fincorp Qualified Institutions PlacementsMay 5, 2026
Announcements
Sidley Represents Archimed in US$1.1 Billion Acquisition of Esperion TherapeuticsMay 1, 2026
Announcements